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A B S T R A C T
COVID-19 represents a major public health issue in Italy; estimating the size of the outbreak could direct
public health policies and inform us of the extent of the reorganization needed in the healthcare system,
the efficacy of quarantine measures, and eventually on the achievement of herd immunity. To chart the
real extent of COVID-19 infection in Italy official data need to be interpreted, considering various aspects
such as the "suspected-case" definition that changed during recent months, the management of
asymptomatic and untested symptomatic cases, the system for reporting deaths, and short-term
fluctuations. All these aspects should be considered when reflecting on the meaning of the official COVID-
19 figures in Italy. Regionalization of the healthcare system and fragmentation of data represent real
challenges in the management of the COVID-19 outbreak in Italy. The authors’ opinion is that transparent
and accurate reporting could guide policy-making and help reorganize health services.
© 2020 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).
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COVID-19 represents a significant public health issue. Mar 11,
2020, the World Health Organization (WHO) officially declared the
COVID-19 outbreak a pandemic (World Health Organization
(WHO), 2020). This virus can easily spread (Wang et al., 2020; Li
et al., 2020) and can lead to asymptomatic cases (Tian et al., 2020;
Mizumoto et al., 2020), mild syndromes (Guan et al., 2020; Wu and
McGoogan, 2020) as well as severe manifestations, requiring
hospitalization and Intensive Care Units (ICU) (Wu and McGoogan,
2020). Italy is among the world's worst-hit countries (Ministry of
Health, Italy, 2020) and the first among Western countries to order
a national lockdown.
Accurate estimates of the size of the outbreak could influence
public health policies. They could inform Covid-19 research on the
necessary reorganization of a healthcare system and on the
efficacy of quarantine measures. Finally, accurate estimates could
improve our understanding of how close we are to the acquisition
of herd immunity.
National bulletins provide us with official data on analyzed
swabs, confirmed cumulative cases, home isolation cases, hospi-
talized cases, ICU cases, and deaths (Ministry of Health, Italy,
2020). However, Russel et al. estimate that Italy is one of the
countries with the highest percentage of unreported cases of* Corresponding author.
E-mail address: marco.delriccio@unifi.it (M. Del Riccio).
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).COVID-19 (Russel et al., 2020). The regionalization of data flow
represents another challenge. Data is communicated daily – in an
aggregate fashion - by every region to the national authorities;
however, there is no standardized collection of data. In parallel,
public health services upload individual data to a surveillance
system’s online platform. While the first data flow is region-
dependent and has the advantage of being updated daily, the
second is more standardized but notifications refer to cases
diagnosed on previous days. In this paper, we will refer to the first
data flow, which has extensively been used by scientists and media
to analyze the pandemic's evolution. Regarding this data flow, the
lack of uniformity among Italian regional data raised the
unconvincing hypothesis of differently virulent SARS-CoV-2 types.
Thus, to track the real extent of COVID-19 infection in Italy, it needs
to be interpreted according to the following points.
Suspected case definition
At the beginning of the epidemic, the definition of “suspected
case” to be tested for SARS-CoV-2 was based on symptoms (fever,
cough, and flu-like symptoms) and a history of traveling or
residence in China or Italian “red areas." This testing policy
explains why the regions of Lombardy and Veneto initially
collected more samples. The definition was later revised as a
person with acute respiratory infection associated with either a
history of travel or residence in an area reporting local transmis-
sion of COVID-19, close contact with a confirmed or probable
COVID-19 case, or requiring hospitalization (Italian Ministry ofciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
Figure 1. Number of daily swabs and daily new cases in Piedmont and Veneto.
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asymptomatic people with close contact with confirmed cases or
asymptomatic people in red areas.
The result is that the proportion of the population tested varies
among regions. The percentage of samples over the total
population ranges from 0.92% in Campania to 5.46% in Veneto
(data updated Apr 21) (Ministry of Health, Italy, 2020).
Taking the proportion of the tested population into consider-
ation helps us interpret official data. For example, Veneto (the
region that tested the most) and Piedmont have recorded similar
numbers of confirmed cases until mid-April. However, the number
of deaths and the number of hospitalized and ICU patients was
much higher in Piedmont. This suggests that a vast number of
infections went undetected in Piedmont. Even though most of
these undetected cases probably presented mild or moderate
symptoms, some critical patients might have died without a
confirmed diagnosis.
Short-term fluctuations
Short-term fluctuations might compromise the reliability of daily
data. These fluctuations are due to laboratory delays – e.g., results
from delays due to laboratory saturation – or calendar effects. The
number of swabs tends to drop on weekends, and thus we notice a
weekly patternin the time series of the numberof swabsand positive
cases (Figure 1). Techniques, such as moving averages, should be
considered in order to account for this variability.
Asymptomatic and untested symptomatic cases
The number of asymptomatic and untested symptomatic
subjects is essential to track the size of the outbreak. In the
literature, there remains a high level of uncertainty in theTable 1
Regional population, number of samples, percentage of samples over the population,
percentage of collected samples over cases, hospitalization ratio, and hospital vs. home ca
(this value is the mean of the ratios calculated daily since the beginning of the pandem







Emilia-Romagna 4,459,477 134,878 3.02 13,244 
Lazio 5,879,082 100,031 1.07 4,402 
Lombardy 10,060,574 277,197 2.76 33,978 
Marche 1,525,271 44,332 2.91 3,218 
Piedmont 4,356,406 105,434 2.42 14,811 
Veneto 4,905,854 268,069 5.46 10,077 
Italy 60,359,546 1,450,150 2.40 78,671 estimates of the percentage of asymptomatic carriers (Centre for
Evidence-Based Medicine (CEBM), 2020). We hypothesize that
untested symptomatic subjects develop mostly mild or moderate
syndromes. Tabata et al., for example, found that 43 out of 104
patients were mildly symptomatic on the “Diamond Princess”
(Tabata et al., 2020).
The reasons for underdiagnosis of asymptomatic and mildly/
moderately symptomatic patients may be:
a) political and healthcare choices;
b) geographic proximity to “red areas” (Giordano et al., 2020);
c) strength and flexibility of public health services and primary
care services;
d) availability of swabs and/or laboratories to analyze samples
(Rubino et al., 2020).
Saturation of ICU
It is worth remarking that the number of ICU patients is given as
daily prevalence data, while the total number of positive cases and
deaths is cumulative. We should consider that the total number of
ICU cases may reflect the saturation of ICU capacity and not the
total need for ICU beds (Grasselli et al., 2020). Moreover, some of
the dead and healed subjects must have previously been taken care
of in ICU. Zhou et al. found that out of 54 deaths in a hospital
setting, 42 had been treated in ICU, i.e., 77.7%) while 12 were never
admitted to ICU - 22.3%, probably because of old age, comorbidities
or lack of ICU beds (Zhou et al., 2020). However, deaths do not
always occur in hospital wards or ICUs. Particularly in those areas
where deaths and recoveries now significantly outnumber
prevalent ICU cases, the percentage of subjects who would need
intensive treatment over the total of infected cases is under-
estimated.
Deaths reporting
The Italian National Institute of Statistics (ISTAT) adopted the
WHO ICD-10 codes ‘U07.1 COVID-19, virus identified’ and ‘U07.2
COVID-19, virus not identified’ to code deaths from COVID-19 as
confirmed or not by laboratory testing. Nonetheless, we expect
underreporting and misclassification.
In Nembro (province of Bergamo), one of the most affected
municipalities, the number of expected deaths in the first three
months of 2020 under normal conditions was 35. 158 deaths were
instead registered by municipal offices. The number of deaths
officially attributed to COVID-19 is 31. It is reasonable to expect that
the deaths in excess occurred at home or in nursing care homes
(Corriere della Sera (CdS), 2020).
However, we cannot exclude some cases of misclassification
due to ascertainment bias, i.e., coding deaths from severe
respiratory syndrome with ‘U07.2 COVID-19, virus not identified’. the cumulative number of reported cases, percentage of cases over population,
re ratio. Hospitalization ratio is the percentage of hospitalized cases over total cases
ic). Hospital vs. Home Care ratio is the percentage of hospitalized cases over cases







0.30 10.18 0.34 0.48
0.07 22.72 0.45 0.76
0.34 8.16 0.46 0.80
0.21 13.78 0.34 0.46
0.34 7.12 0.39 0.63
0.21 26.60 0.21 0.23
0.18 18.43 0.35 0.46
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According to official statistics,13.40% of confirmed cases died by
Apr 21, varying between 4.43% in Umbria and 18.52% in Lombardy.
Mizumoto et al. suggest that elevated death risk estimates can be
the consequence of a breakdown of the healthcare system
(Mizumoto and Chowell, 2020). This is consistent with the Italian
figures indicating that Northern regions of Lombardy and Emilia
Romagna have both the highest cumulative incidences and highest
CFRs. However, a time lag occurs between infections and deaths. If
the curve of deaths follows the curve of cases, the death curve in
first-hit regions (Lombardy and Emilia Romagna) might precede
those of other regions.
The Italian official CFR is higher than those of South Korea and
Germany. Both South Korea and Germany analyzed a lot of samples
and, as a result, have a wider coverage of diagnosis, increasing the
denominator of the CFR (Rodriguez-Morales et al., 2020). Verity
et al. found CFR values ranging from 2.7% to 3.6% (Verity et al.,
2020). As noted by Onder et al., the proportion of positive cases
over total samples positively correlates with the CFR (Onder et al.,
2020).
Conclusions
Regionalization of the healthcare system and fragmentation of
data represent challenges in the management of the COVID-19
outbreak in Italy. The lack of a strong centralized response to the
emergency resulted in different regional policies, especially in
terms of testing strategies.
Table 1 shows regional differences in surveillance and
containment strategies and measures. In particular, it emerges
how some regions tested more than others (e.g., Veneto collected
26.60 samples for each case while Piedmont only 7.12 for each
case) and how different was the management of the disease among
different areas (e.g., Veneto hospitalized, on average, 21% of COVID-
19 patients, while Lombardy hospitalized, on average, 46% of
COVID-19 patients). It is of utter importance to develop a system
for informing infectious diseases based on a constantly updated
and unique platform at a national level, possibly fed by laboratory
data and linked to clinical records and other administrative
databases. A transparent and accurate reporting could guide
policy-making and help reorganize health services (Rodriguez-
Morales et al., 2020).
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